These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20522060)

  • 1. Implantable cardioverter-defibrillator shock: appropriate or inappropriate?
    Nault MA; McIntyre WF; Simpson CS; Redfearn DP; Abdollah H; Brennan FJ; Baranchuk A
    Ann Noninvasive Electrocardiol; 2010 Apr; 15(2):181-3. PubMed ID: 20522060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
    Ganjehei L; Nazeri A; Massumi A; Razavi M
    Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator.
    Neglia JJ; Krol RB; Giorgberidze I; Mathew P; Lewis C; Munsif AN; Saksena S
    J Interv Card Electrophysiol; 1997 Feb; 1(1):49-56. PubMed ID: 9869951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator.
    Wietholt D; Block M; Isbruch F; Böcker D; Borggrefe M; Shenasa M; Breithardt G
    J Am Coll Cardiol; 1993 Mar; 21(4):885-94. PubMed ID: 8185728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study).
    Mastenbroek MH; Pedersen SS; van der Tweel I; Doevendans PA; Meine M
    Am J Cardiol; 2016 Feb; 117(4):596-604. PubMed ID: 26732419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
    Dallaglio PD; Anguera I; Martínez Ferrer JB; Pérez L; Viñolas X; Porres JM; Fontenla A; Alzueta J; Martínez JG; Rodríguez A; Basterra N; Sabaté X
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):709-717. PubMed ID: 29242102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An "inappropriately appropriate" shock in a subcutaneous implantable cardioverter-defibrillator: The importance of the SMART pass algorithm.
    Rubio Campal JM; Benezet-Mazuecos J; Sánchez-Borque P; Blanco ÁM; Crosa J; Arias MA
    J Electrocardiol; 2018; 51(6):941-944. PubMed ID: 30497752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study.
    Ruiz-Granell R; Dovellini EV; Dompnier A; Khalighi K; García-Campo E; Olivier A; Barcelo A; Ritter P
    Heart Rhythm; 2019 Sep; 16(9):1429-1435. PubMed ID: 30910709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks.
    Strik M; Ramirez FD; Welte N; Bonnin T; Abu-Alrub S; Eschalier R; Haïssaguerre M; Ritter P; Ploux S; Bordachar P
    Heart Rhythm; 2020 Dec; 17(12):2072-2077. PubMed ID: 32739474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.
    Gasparini M; Lunati MG; Proclemer A; Arenal A; Kloppe A; Martínez Ferrer JB; Hersi AS; Gulaj M; Wijffels MCE; Santi E; Manotta L; Varma N
    JACC Clin Electrophysiol; 2017 Nov; 3(11):1275-1282. PubMed ID: 29759624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.
    Bozyel S; Aktas M; Mutluer FO; Guler TE; Dervis E; Argan O; Celikyurt U; Agir A; Vural A
    Acta Cardiol; 2019 Jun; 74(3):246-251. PubMed ID: 30058473
    [No Abstract]   [Full Text] [Related]  

  • 13. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator].
    Kühlkamp V; Dörnberger V; Mermi J; Mewis C; Seipel L
    Z Kardiol; 1996 May; 85(5):306-11. PubMed ID: 8711942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy).
    Biton Y; Huang DT; Goldenberg I; Rosero S; Moss AJ; Kutyifa V; McNitt S; Strasberg B; Zareba W; Barsheshet A
    Heart Rhythm; 2016 Apr; 13(4):888-93. PubMed ID: 26711799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks.
    Joung B; Lexcen DR; Ching CK; Silver MT; Piccini JP; Sterns LD; Rabinovich R; Pickett RA; Liu S; Brown ML; Cheng A
    Heart Rhythm; 2020 Jan; 17(1):98-105. PubMed ID: 31369873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
    Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
    Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
    Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing.
    Bennett MT; Leader N; Sapp J; Parkash R; Gardner M; Healey JS; Thibault B; Sterns L; Essebag V; Birnie D; Sivakumaran S; Nery P; Andrade JG; Krahn AD; Tang A
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005921. PubMed ID: 29618476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.